1,664
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1359-1362 | Received 20 Mar 2020, Accepted 05 Jun 2020, Published online: 22 Jun 2020

References

  • Supuran CT, Altamimi ASA, Carta F. Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013–2019. Expert Opin Ther Pat 2019;29:781–92.
  • Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467–74.
  • Nowbar AN, Gitto M, Howard JP, et al. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes 2019;12:e005375.
  • Gamble W. Atherosclerosis: the carbonic anhydrase, carbon dioxide, calcium concerted theory. J Theor Biol 2006;239:16–21.
  • Goodman WG, London G, Amann K, et al. Vascular calcification in chronic kidney disease. Am J. Kidney Dis 2000;43:572e579.
  • Ramanan R, Kannan K, Sivanesan S, et al. Bio-sequestration of carbon dioxide using carbonic anhydrase enzyme purified from Citrobacter freundii. World J Microbiol Biotech 2009;25:981e987.
  • Ramanan R, Kannan K, Deshkar A, et al. Enhanced algal CO(2) sequestration through calcite deposition by Chlorella sp. and Spirulina platensis in a mini-raceway pond. Bioresour Technol 2010;101:2616e2622.
  • Mirjafari P, Asghari K, Mahinpey N. Investigating the application of enzyme carbonic anhydrase for CO2 sequestration purposes. Industrial Eng Chem Res 2007;46:921e926.
  • Adeva-Andany MM, Fernández-Fernández C, Sánchez-Bello R, et al. The role of carbonic anhydrase in the pathogenesis of vascular calcification in humans. Atherosclerosis 2015;241:183–91.
  • Taskin MI, Bilen C, Ergun A, et al. In vitro effects of estrogen and progesterone containing drugs on human erythrocyte carbonic anhydrase I and II isozymes in women smokers and nonsmokers. J Chin Med Assoc 2015;78:513–9.
  • Sarıoglu N, Bilen C, Sackes Z, et al. The effects of bronchodilator drugs and antibiotics used for respiratory infection on human erythrocyte carbonic anhydrase I and II isozymes. Arch Physiol Biochem 2015;121:56–61.
  • Koc ER, Erken G, Bilen C, et al. The effects of anti-epileptic drugs on human erythrocyte carbonic anhydrase I and II isozymes. Arch Physiol Biochem 2014;120:131–5.
  • Erzengin M, Bilen C, Ergun A, et al. Antipsychotic agents screened as human carbonic anhydrase I and II inhibitors. Arch Physiol Biochem 2014;120:29–33.
  • Bozdag M, Isik S, Beyaztas S, et al. Synthesis of a novel affinity gel for the purification of carbonic anhydrases. J Enzyme Inhib Med Chem 2015;30:240–4.
  • Maren TH. A simplified micromethod for the determination of carbonic anhydrase and its inhibitors. J Pharm Exp Ther 1960;130:2629–34.
  • Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221–9.
  • Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Am Chem Soc 1934;56:658–66.
  • Pintarić H, Zeljković I, Babić Z, et al. Electrophysiological predictors of propafenone efficacy in prevention of atrioventricular nodal re-entrant and atrioventricular re-entrant tachycardia. Croat Med J 2012;53:605–11.
  • Obach RS, Huynh P, Allen M, et al. Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol 2004; 44:7–19.
  • Rodondi N, Taylor BC, Bauer DC, et al. Association between aortic calcification and total and cardiovascular mortality in older women. J Intern Med 2007;261:238–44.
  • Oksala N, Levula M, Pelto-Huikko M, et al. Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques – Tampere Vascular Study. Ann Med 2010;42:360–70.
  • Ayari H, Bricca G. Microarray analysis reveals overexpression of IBSP in human carotid plaques. Adv Med Sci 2012;57:334H.
  • Yuan L, Wang M, Liu T, et al. Carbonic anhydrase 1-mediated calcification is associated with atherosclerosis, and methazolamide alleviates its pathogenesis. Front Pharmacol 2019;10:766.
  • Ye YC, Zhao XL, Zhang SY. Use of atorvastatin in lipid disorders and cardiovascular disease in Chinese Patients. Chin Med J (Engl) 2015;128:259–66.
  • Choi JS, Ha SI, Choi DH. Effects of atorvastatin on the pharmacokinetics of nicardipine after oral and intravenous administration in rats. Biomol Therap 2010;18:226–32.
  • Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111–88.
  • de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 2004;292:1307–16.
  • Navarese EP, Kowalewski M, Andreotti F, et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol 2014;113:1753–64.
  • Ray KK, Cannon CP, McCabe CH, et al. Early and late benefits of highdose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005;46:1405–10.
  • Schwartz GG, Fayyad R, Szarek M, et al. Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome. Eur J Prev Cardiol 2017;24:1294–6.
  • Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711.
  • Parkkila S, Vullo D, Maresca A, et al. Serendipitous fragment-based drug discovery: ketogenic diet metabolites and statins effectively inhibit several carbonic anhydrases. Chem Commun (Camb) 2012;48:3551–3.
  • Pihlanto-Leppala A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998;8:325–31.
  • Lonn E. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis. Curr Atheroscler Rep 2002;4:363–72.
  • Sozzani S, Agwu D, Mccall C, et al. Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein-kinase-C. J Biological Chem 1992;267:20481–8.
  • Almotrefi A, Dzimiri N. Effects of beta-adrenoceptor blockers on mitochondrial ATpase activity in guinea-pig heart preparations. Eur J Phar 1992;215:231–6.
  • Puşcas I, Reznicek A, Moldovan A, et al. Activation of carbonic anhydrase by beta-adrenergic agonists and inhibition by beta-adrenergic blockers. Med Int 1985;23:185–9.
  • Shankar SS, Brater DC. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 2003;284:F11–21.
  • Temel Y, Ayna A, Shafeeq IH, et al. In vitro effects of some antibiotics on glucose-6-phosphate dehydrogenase from rat (Rattus norvegicus) erythrocyte. Drug Chem Toxicol 2020;43:219–23.
  • Carta F, Supuran CT. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005–2013). Expert Opin Ther Pat 2013;23:681–91.
  • Altıntop MD, Sever B, Özdemir A, et al. Potential inhibitors of human carbonic anhydrase isozymes I and II: design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives. Bioorg Med Chem 2017;25:3547–54.